An Analysis of Effect Stratification and Influencing Factors After the First 131I Treatment After Surgery for Intermediate and High-Risk Differentiated Thyroid Cancer

WEN Runze, CHEN Xinying, ZHANG Jing, ZHAO Min, LU Yixing, DENG Shengming, ZHANG Bin

PDF(1779 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1779 KB)
Labeled Immunoassays and Clinical Medicine ›› 2023, Vol. 30 ›› Issue (1) : 78-85. DOI: 10.11748/bjmy.issn.1006-1703.2023.01.015
Clinical Investigation

An Analysis of Effect Stratification and Influencing Factors After the First 131I Treatment After Surgery for Intermediate and High-Risk Differentiated Thyroid Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 30(1): 78-85 https://doi.org/10.11748/bjmy.issn.1006-1703.2023.01.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1779 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉